)
)
Biotest Investor Relations Material
Latest events
H2 2022
Biotest
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Biotest Aktiengesellschaft
Access all reports
Biotest Aktiengesellschaft is a German-based company that specializes in the development, production, and marketing of plasma proteins and biological drugs. The company’s primary focus areas include clinical immunology, hematology, and intensive care medicine. Biotest’s product portfolio includes immunoglobulins, coagulation factors, and albumins, which are derived from human blood plasma and are utilized in treating immune and hematopoietic system disorders. Additionally, the company engages in the development of monoclonal antibodies for treating conditions such as cancer of plasma cells and systemic lupus erythematosus. The company is headquartered in Dreieich, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
BIO3
Country
🇩🇪 Germany